ClinConnect ClinConnect Logo
Search / Trial NCT03301792

Group Versus Traditional Prenatal Care for Diabetes

Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Oct 3, 2017

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Group Prenatal Care Diabetes

ClinConnect Summary

Long term, the investigator aims to test the central hypothesis that group prenatal care, compared to traditional prenatal care, will improve, 1.) glycemic control and, 2.) postpartum weight retention in women with type 2 and gestational diabetes. The objective of this proposal is to conduct a randomized trial in two phases to determine the effect of Diabetes Group Care (GC) on glycemic control in pregnant women with T2DM and GDM (Antepartum Phase) and the impact on postpartum weight retention (Postpartum Phase).

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. English speaking
  • 2. Type 2 diabetes OR gestational diabetes diagnosed by 2-step method(1) OR likely pre-existing Type 2 diabetes with one of the following during pregnancy and \</= 34 weeks:
  • 1. 1 hour glucose challenge test \>/= 185mg/dL OR
  • 2. A1c \>/= 6.5% OR
  • 3. Fasting plasma glucose \> 126mg/dL (2)
  • 3. Ability to attend group prenatal visit at specified days and times
  • 4. Willingness to be randomized at 22 weeks 0 days-34 weeks 0 days OR initial visit between 24 weeks 0 days-34 weeks 0 days
  • 5. Ability to give informed consent
  • Exclusion Criteria:
  • 1. Prior participation in diabetes group care
  • 2. Type 1 Diabetes
  • 3. Multiple gestation
  • 4. Major fetal anomaly
  • 5. Serious medical co-morbidity necessitating more care than can be safely provided in group setting, as deemed by medical provider.
  • 6. Serious psychiatric illness including schizophrenia necessitating more care than can safely be provided in group setting, as deemed by medical provider.

About Washington University School Of Medicine

Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.

Locations

Saint Louis, Missouri, United States

Patients applied

0 patients applied

Trial Officials

Megan Lawlor, MD

Principal Investigator

Assistant Professor, Washington University in St. Louis

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials